Protocol summary

Study aim
Improving the quality of life of patients
Design
Triple blinded intervention Randomize clinical Trial -triple blinded - controlled Simple randomization of available patients Phase 3
Settings and conduct
From the hospitals and offices of oncologists in Qom, the files of all cancer patients who have sought treatment for chemotherapy drugs, including Capecitabine Dejar Syndrome, have been extracted, and eligible patients are divided into intervention and control groups. Demographic information, type and stage of cancer of patients will be recorded.
Participants/Inclusion and exclusion criteria
معیارهای ورود: تمام بیماران بالای 18 سال مبتلا به سندروم دست و پای ناشی از شیمی درمانی، از جمله داروی Capecitabine، که رضایت به شرکت در مطالعه دارند. معیارهای عدم ورود: بیماران مبتلا به دیگر ضایعات پوستی- وجود عفونت- بیماری التهابی روده- سابقه حساسیت شدیدبه شیر Inclusion criteria: All patients over 18 years of age with chemotherapy-induced hand and foot syndrome, including Capecitabine, who agree to participate in the study. Criteria for not entering: Patients with other skin lesions - Infection - Inflammatory bowel disease - History of severe milk allergy
Intervention groups
The intervention group consumes 15 grams of malt powder twice a day, in the morning and in the evening, which should be dissolved in 100 cc of lukewarm boiled water, and sip, and eat something until one hour after consumption. Do not use. Mercury will be used for 6 weeks and 2 days. At the same time, both control and intervention groups, 20% glycerin ointment; Use topically.
Main outcome variables
Common Terminology Criteria for Adverse Event, Edition 5, including the definition of three degrees of the syndrome, grades 1, 2, and 3, to assess the degree of lesion Pain rate, Evaluation of redness and scaling of skin lesions Evaluation of burning, itching and, numbness of skin lesions

General information

Reason for update
Acronym
EMCHFS
IRCT registration information
IRCT registration number: IRCT20220317054317N1
Registration date: 2022-04-04, 1401/01/15
Registration timing: prospective

Last update: 2022-04-04, 1401/01/15
Update count: 0
Registration date
2022-04-04, 1401/01/15
Registrant information
Name
Akram Ashoori
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 25 3293 7569
Email address
aashori@muq.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-05-05, 1401/02/15
Expected recruitment end date
2024-05-04, 1403/02/15
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effect of "Maoljobon ( whey)" on Cancer patients with chemotherapy_ induced "hand and foot syndrome" and their quality of life
Public title
The effect of "Maoljobon ( whey)" on Cancer patients with chemotherapy induced "hand and foot syndrome"
Purpose
Supportive
Inclusion/Exclusion criteria
Inclusion criteria:
All patients over 18 years of age with hand syndrome and reason for chemotherapy, from Capecitabine, who are willing to participate in the study.
Exclusion criteria:
Patients with other skin lesions - Infection - Inflammatory bowel disease - History of severe milk allergy
Age
From 18 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Data analyser
  • Data and Safety Monitoring Board
Sample size
Target sample size: 60
Randomization (investigator's opinion)
Randomized
Randomization description
In the first step, the groups are written as groups A and B. A lottery is then drawn between the two groups to determine which letter is in the intervention group and which is in the control group. In the second step, 60 numbers, from one to 60, are written on paper and completely closed so that they are not visible and are thrown into a container. Then, in the third step, a person will announce that the patients will choose the intervention or control group, then pick up a number from the container and read it and take notes in the group that announced it. This is done 30 times without substitution until all the people in the announced group are identified, then the remaining 30 numbers are assigned to the second group. Finally, when patients come to the clinic, each patient has a number from inside a container that contains 60 numbers from one to 60 and is written on paper and is not visible, and gives it to the therapist, then the therapist opens the number paper and Looks at the list of groups. The selected number belongs to each group. The patient is placed in that group and this is done up to 60 times to complete the groups.
Blinding (investigator's opinion)
Triple blinded
Blinding description
During the study and sampling, the therapist, researcher and patients will not know the type of group (control or intervention) and try to invite patients to visit at a distance so as not to meet each other and not be informed about the content of the treatment. The distribution of medicine according to the group list will be done by one of the staff of the center who is not involved in the examination and collection of information. After collecting the data, the analyzers will not know the patient group
Placebo
Not used
Assignment
Other
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of ًQom University of Medical Sciences
Street address
Safashahr St., University Jihad Alley, Shahid Lotfi Niasar (Alley No. 4), No. 83
City
qom
Province
Ghoum
Postal code
3713649373
Approval date
2022-03-06, 1400/12/15
Ethics committee reference number
IR.MUQ.REC.1400.244

Health conditions studied

1

Description of health condition studied
Chemotherapy-induced hand and foot syndrome
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
The amount of pain in the lesions
Timepoint
Before the intervention, one day and one week after the intervention period
Method of measurement
visual analog scale

2

Description
Degree of waste
Timepoint
Before the intervention, one day and one week after the intervention period
Method of measurement
Common Terminology Criteria for Adverse Event

3

Description
The amount of burning and itching and numbness of the lesions
Timepoint
Before the intervention, one day and one week after the intervention period
Method of measurement
Likert Questionnaire

4

Description
Scaling rate and redness of the lesions
Timepoint
Before the intervention, one day and one week after the intervention period
Method of measurement
Dermatologist photography and opinion

Secondary outcomes

1

Description
Overall quality of life
Timepoint
before the intervention and one day and one week after the intervention period
Method of measurement
(Quality of Life)questionnaire

2

Description
Quality of life of a skin patient
Timepoint
before the intervention and one day and one week after the intervention period
Method of measurement
Dermatology Life Quality Index questionnaire

Intervention groups

1

Description
The brewery is the whey that is obtained as a by-product of cheese production, after the separation of milk casein, and contains lactose and a variety of proteins, minerals, vitamins, and fats. Depending on the type of milk and methods of this process, various products are created. In this project, among the methods of coagulation of milk in traditional medicine by vinegar, peppermint or shoe eggs, the type of peppermint has been selected. Freshly boiled milk will be cut through powdered sugar and a little vinegar. After the milk is completely cut, the container is removed from the fire. The contents of the container, which is still slightly warm, are poured into a fine-textured canvas cloth and the water is collected in a container. After collecting the liquid, it is turned into powder in the freezer and packaged Intervention group: People in the intervention group consumed 15 grams of malt powder twice a day, morning, morning, and evening, which should be dissolved in 100 ccs of lukewarm boiled water, and sip, and consumed until one hour later. Do not eat anything. The use of malt water will be for 6 weeks and 2 days. At the same time, for both control and intervention groups, 20% glycerin ointment; Use topically.After preparing the powder in one of the reputable laboratories, it is examined for fungi and microbes, and after making sure that no microbial and fungal counts have grown in the powder product, it will enter the clinical phase.
Category
Rehabilitation

Recruitment centers

1

Recruitment center
Name of recruitment center
Hospitals and oncologist offices in qom
Full name of responsible person
Akram Ashoori
Street address
15 Khordad Boulevard, next to Alley 44, Qom School of Persian Medicine
City
Qom
Province
Ghoum
Postal code
3716655398
Phone
+98 25 3776 4073
Email
aashori@muq.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Ghoum University of Medical Sciences
Full name of responsible person
Alireza Koohpaei
Street address
Qom - Safashahr St. - University Jihad Alley - Shahid Lotfi Niasar (Alley No. 4) - No. 8
City
Qom
Province
Ghoum
Postal code
3716993456
Phone
+98 25 3285 2720
Fax
+98 25 3285 8464
Email
research@mail.muq.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Ghoum University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Ghoum University of Medical Sciences
Full name of responsible person
Akram Ashoori
Position
Associate
Latest degree
Medical doctor
Other areas of specialty/work
Traditional Medicine
Street address
15 Khordad Boulevard, next to Alley 44, Qom School of Persian Medicine
City
Qom
Province
Ghoum
Postal code
3714848350
Phone
+98 25 3776 4073
Email
aashori@muq.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Ghoum University of Medical Sciences
Full name of responsible person
Majid Asghari
Position
Consultant
Latest degree
Ph.D.
Other areas of specialty/work
Traditional Medicine
Street address
15 Khordad Boulevard, next to Alley 44, Qom School of Traditional Medicine
City
Qom
Province
Ghoum
Postal code
3714848350
Phone
+98 25 3776 4073
Email
Asghari.rall@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Ghoum University of Medical Sciences
Full name of responsible person
Akram Ashoori
Position
Associate
Latest degree
Medical doctor
Other areas of specialty/work
Traditional Medicine
Street address
15 Khordad Boulevard, next to Alley 44, Qom School of Persian Medicine
City
Qom
Province
Ghoum
Postal code
3714848350
Phone
+98 25 3776 4073
Email
aashori@muq.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Not applicable
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Data will be sent on request by researchers.
When the data will become available and for how long
After printing the study results
To whom data/document is available
researchers
Under which criteria data/document could be used
For systematic review studies or meta-analysis
From where data/document is obtainable
Dr. Majid Asghari
What processes are involved for a request to access data/document
Correspondence by email with the project manager
Comments
Loading...